Your session is about to expire
← Back to Search
Xenon Inhalation Therapy for Depression
Study Summary
This trial is testing whether inhaling xenon gas can help people with treatment-resistant depression. The study is comparing the effects of adding xenon to treatment as usual to adding nitrogen to treatment as usual.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently taking a benzodiazepine medication.I do not have any uncontrolled serious health conditions.I do not have any serious lung conditions.I can follow the study's schedule and procedures.I am between 18 and 65 years old.I have not taken any experimental mental health drugs in the past 6 months.I have been on a stable antidepressant or mood stabilizer for over 4 weeks.I have a dependable way to get to and from my home.I have not abused substances or been dependent on them in the past year, and I do not currently smoke anything.I have had a brain injury or a condition with trapped air that could expand inside my body.I have been diagnosed with a mental health condition such as MDD, bipolar disorder with psychosis, schizophrenia, OCD, or an anxiety disorder.I have been diagnosed with major depression or bipolar depression.I understand the risks and benefits of this trial and can give my consent.You have had a bad reaction to xenon in the past, or you have experienced multiple negative reactions to medications.I have no health issues preventing me from receiving treatments with xenon or nitrogen-oxygen mixtures.
- Group 1: X-TAU (xenon)
- Group 2: N-TAU (nitrogen-placebo)
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this medical experiment open to individuals younger than fifty-five years of age?
"In order to participate in this trial, subjects must be aged between 18 and 65. There are 418 medical studies with a lower age threshold and 1503 trials open for those beyond the upper limit of 65 years old."
Is this research actively enrolling participants?
"Affirmative. Data hosted on clinicaltrials.gov states that this medical study is currently recruiting individuals, with 20 participants sought from a single centre. The trial was initiated on December 5th 2019 and last updated February 23rd 2022."
Is there an eligibility criteria for enrolling in this clinical research?
"In order to gain entry into this medical trial, an individual must experience psychosis, involutional depression, and be between 18-65 years old. The total number of participants required for the study is 20 individuals."
What is the participant quota for this medical study?
"Affirmative. According to the information provided by clinicaltrials.gov, this medical research is actively enrolling patients that meet its criteria; it was first made public on December 5th 2019 and recently updated on February 23rd 2022. The trial seeks 20 participants from a single location."
What prior investigations have utilized xenon as an element?
"Currently, 18 independent research projects are being conducted on X-TAU (xenon), none of which have reached Phase 3. Philadelphia, Pennsylvania hosts the majority of these trials; however 25 different sites have trials open for this drug's efficacy."
What clinical conditions commonly warrant the use of X-TAU (xenon)?
"X-TAU (xenon) is usually used to treat actinic keratosis, yet it also has the potential of managing hypoxemia, respiratory challenge test and certain types of verruca (warts)."
Share this study with friends
Copy Link
Messenger